My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.

    Ohguro N, Matsuda M, Ohashi Y, Fukuda M.

    Br J Ophthalmol. 1995 Dec;79(12):1074-7.PMID: 8562538 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.

    Hosotani H, Ohashi Y, Yamada M, Tsubota K.

    Am J Ophthalmol. 1995 Mar;119(3):288-94.PMID: 7872388 [PubMed - indexed for MEDLINE]Related articles

    3.

    Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.

    Ohashi Y, Matsuda M, Hosotani H, Tano Y, Ishimoto I, Fukuda M, Manabe R.

    Am J Ophthalmol. 1988 Mar 15;105(3):233-8.PMID: 3125744 [PubMed - indexed for MEDLINE]Related articles

    4.

    Topical aldose reductase inhibitor.

    Coster D.

    Br J Ophthalmol. 1995 Dec;79(12):1064-5. No abstract available. PMID: 8562535 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.

    Hosotani H, Ohashi Y, Kinoshita S, Matsumoto T, Awata T.

    Curr Eye Res. 1996 Oct;15(10):1005-7.PMID: 8921238 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effect of aldose reductase inhibitor on the corneal epithelium.

    Tsubota K, Yamada M.

    Cornea. 1993 Mar;12(2):161-2.PMID: 8500324 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.

    Ohashi Y, Awata T, Sogo S, Ohira M, Matsuda M, Fukuda M, Manabe R.

    J Ocul Pharmacol. 1989 Winter;5(4):325-8.PMID: 2516866 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.

    Matsuda M, Awata T, Ohashi Y, Inaba M, Fukuda M, Manabe R.

    Curr Eye Res. 1987 Feb;6(2):391-7.PMID: 2952464 [PubMed - indexed for MEDLINE]Related articles

    9.

    Corneal endothelial morphology in the rat. Effects of aging, diabetes, and topical aldose reductase inhibitor treatment.

    Meyer LA, Ubels JL, Edelhauser HF.

    Invest Ophthalmol Vis Sci. 1988 Jun;29(6):940-8.PMID: 2967259 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

    Nakahara M, Miyata K, Otani S, Miyai T, Nejima R, Yamagami S, Amano S.

    Br J Ophthalmol. 2005 Mar;89(3):266-8.PMID: 15722300 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.

    Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A.

    Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2201-4.PMID: 2122961 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Discoveries in research on diabetic keratopathy.

    Cisarik-Fredenburg P.

    Optometry. 2001 Nov;72(11):691-704. Review.PMID: 12363257 [PubMed - indexed for MEDLINE]Related articles

    13.

    Corneal endothelial changes in patients with chronic renal failure.

    Ohguro N, Matsuda M, Fukuda M.

    Am J Ophthalmol. 1999 Aug;128(2):234-6.PMID: 10458183 [PubMed - indexed for MEDLINE]Related articles

    14.

    Corneal endothelium in patients with diabetes mellitus: a historical cohort study.

    Shenoy R, Khandekar R, Bialasiewicz A, Al Muniri A.

    Eur J Ophthalmol. 2009 May-Jun;19(3):369-75.PMID: 19396780 [PubMed - indexed for MEDLINE]Related articles

    15.

    Corneal endothelium evaluation in type I and type II diabetes mellitus.

    Roszkowska AM, Tringali CG, Colosi P, Squeri CA, Ferreri G.

    Ophthalmologica. 1999;213(4):258-61.PMID: 10420110 [PubMed - indexed for MEDLINE]Related articles

    16.

    Corneal abnormalities in diabetes.

    Siribunkum J, Kosrirukvongs P, Singalavanija A.

    J Med Assoc Thai. 2001 Aug;84(8):1075-83.PMID: 11758839 [PubMed - indexed for MEDLINE]Related articles

    17.

    Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study.

    Fujishima H, Shimazaki J, Yagi Y, Tsubota K.

    Cornea. 1996 Jul;15(4):368-75.PMID: 8776562 [PubMed - indexed for MEDLINE]Related articles

    18.

    Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy.

    Lee JS, Lee JE, Choi HY, Oum BS, Cho BM.

    J Cataract Refract Surg. 2005 Apr;31(4):742-9.PMID: 15899451 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235.

    Fujishima H, Tsubota K.

    Br J Ophthalmol. 2002 Aug;86(8):860-3.PMID: 12140204 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Structure and function of the corneal endothelium in diabetes mellitus type I and type II.

    Larsson LI, Bourne WM, Pach JM, Brubaker RF.

    Arch Ophthalmol. 1996 Jan;114(1):9-14.PMID: 8540858 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity